Evidence map›Paper›PMID 12138189›Full record

ArticleMolecular and cellular biology2002

Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.

Dangsheng Li, Tong Li, Fang Wang, Heather Tian, Herbert H Samuels

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dangsheng LiDepartment of Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Tong Li
Fang Wang
Heather Tian
Herbert H Samuels
New York University · US

Funding

METABOLIC EFFECTS OF THYROID HORMONE IN CELL CULTURER01DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1986 to 2007
$6.0M
Metabolic Effects of Thyroid HormoneR56DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 2009 to 2009
$211k
NUCLEAR RECEPTOR INTERACTING FACTORSF32DK009581 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LI, DANGSHENG · 1997 to 1999
–
METABOLIC EFFECTS OF THYROID HORMONER37DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1991 to 1998
–
NIDDK NIH HHS DK09581NIDDK NIH HHS DK16636NIDDK NIH HHS F32 DK009581NIDDK NIH HHS R01 DK016636NIDDK NIH HHS R56 DK016636
6 · The paper itself

Abstract

Many members of the thyroid hormone/retinoid receptor subfamily (type II nuclear receptors) function as heterodimers with the retinoid X receptor (RXR). In heterodimers which are referred to as permissive, such as peroxisome proliferator activated receptor/RXR, both partners can bind cognate ligands and elicit ligand-dependent transactivation. In contrast, the thyroid hormone receptor (TR)/RXR heterodimer is believed to be nonpermissive, where RXR is thought to be incapable of ligand binding and is often referred to as a silent partner. In this report, we used a sensitive derepression assay system that we developed previously to reexamine the TR/RXR interrelationship. We provide functional evidence suggesting that in a TR/RXR heterodimer, the RXR component can bind its ligand in vivo. Ligand binding by RXR does not appear to directly activate the TR/RXR heterodimer; instead, it leads to a (at least transient or dynamic) dissociation of a cellular inhibitor(s)/corepressor(s) from its TR partner and thus may serve to modulate unliganded TR-mediated repression and/or liganded TR-mediated activation. Our results argue against the current silent-partner model for RXR in the TR/RXR heterodimer and reveal an unexpected aspect of cross regulation between TR and RXR.

Indexed as

AlitretinoinAnticarcinogenic AgentsBexaroteneDimerizationDNA-Binding ProteinsGene Expression RegulationGenes, ReporterHeLa CellsHerpes Simplex Virus Protein Vmw65HumansLigandsNuclear ProteinsReceptors, Retinoic AcidReceptors, Thyroid HormoneRecombinant Fusion ProteinsRetinoid X ReceptorsAlitretinoinAnticarcinogenic AgentsBexaroteneDNA-Binding ProteinsHerpes Simplex Virus Protein Vmw65LigandsNuclear ProteinsReceptors, Retinoic AcidReceptors, Thyroid HormoneRecombinant Fusion ProteinsRetinoid X ReceptorsTetrahydronaphthalenesTranscription FactorsTretinoinTriiodothyronine

Identifiers

PMID12138189
PMCPMC133993
OpenAlexW2115229208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.